NCT00297791 2024-08-21
COLORII
Nova Scotia Health Authority
Phase 3 Completed
Clinical Trials
17 trialsNCT02363374 2023-12-04
CAOAROAIO-12
Goethe University
Phase 2 Completed
NCT06113796 2023-11-02
Economic Analysis of Robotic Rectal Resection in German Health Care System
Universitätsklinikum Hamburg-Eppendorf
Completed
NCT02017704 2023-10-17
CORRECT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01444495 2023-02-15
Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer
Jagiellonian University
Phase NA Completed
NCT05108753 2021-11-05
Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China
Shanghai Minimally Invasive Surgery Center
Completed
NCT01363843 2020-06-11
Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)
Brown University
Phase 2 Completed
NCT00081289 2020-02-27
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT03265418 2019-09-04
BioXmark, Rectal Feasibility Trial
Maastricht Radiation Oncology
Phase NA Completed
NCT00535041 2019-03-01
Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT02017509 2018-08-29
Immunoscore in Rectal Cancer
Providence Health & Services
Completed
NCT00310076 2018-08-23
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00865189 2017-08-04
INOVA
Hoffmann-La Roche
Phase 2 Completed
NCT01749956 2017-02-07
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00543842 2015-02-26
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00215956 2013-12-23
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00003544 2013-06-26
Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed